Published in J Virol on March 01, 1993
Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J Virol (1997) 2.24
Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol (1996) 2.12
Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev (2001) 2.06
Definition of a domain of GLVR1 which is necessary for infection by gibbon ape leukemia virus and which is highly polymorphic between species. J Virol (1993) 1.99
Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses. J Virol (1996) 1.97
Murine endogenous retroviruses. Cell Mol Life Sci (2008) 1.85
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol (1995) 1.82
Characterization of a naturally occurring ecotropic receptor that does not facilitate entry of all ecotropic murine retroviruses. J Virol (1993) 1.72
Identification and characterization of the viral interaction determinant of the subgroup A avian leukosis virus receptor. J Virol (1995) 1.66
Glycosylation-dependent inactivation of the ecotropic murine leukemia virus receptor. J Virol (1994) 1.62
Retrovirus infection: effect of time and target cell number. J Virol (1995) 1.51
Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J Virol (1997) 1.44
Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry. J Virol (1996) 1.39
The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34
Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci U S A (1996) 1.30
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol (1996) 1.26
Analysis of the unique hamster cell tropism of ecotropic murine leukemia virus PVC-211. J Virol (1996) 1.25
Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol (1996) 1.21
A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses. J Virol (2002) 1.07
Sodium-dependent myo-inositol transporter 1 is a cellular receptor for Mus cervicolor M813 murine leukemia virus. J Virol (2003) 1.01
Comprehensive mapping of receptor-functioning domains in feline leukemia virus subgroup C receptor FLVCR1. J Virol (2006) 1.01
Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway. J Virol (1999) 1.01
A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor. J Virol (1999) 0.97
Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter. J Virol (1996) 0.96
Turning of the receptor-binding domains opens up the murine leukaemia virus Env for membrane fusion. EMBO J (2008) 0.93
Analysis of receptor usage by ecotropic murine retroviruses, using green fluorescent protein-tagged cationic amino acid transporters. J Virol (1999) 0.90
Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus. Retrovirology (2005) 0.89
Role of receptor polymorphism and glycosylation in syncytium induction and host range variation of ecotropic mouse gammaretroviruses. Retrovirology (2008) 0.86
Novel postentry resistance to AKV ecotropic mouse gammaretroviruses in the African pygmy mouse, Mus minutoides. J Virol (2008) 0.84
Identification of a critical basic residue on the ecotropic murine leukemia virus receptor. J Virol (2003) 0.83
Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species. Retrovirology (2007) 0.83
Complementation of a binding-defective retrovirus by a host cell receptor mutant. J Virol (2004) 0.82
Contribution of virus-receptor interaction to distinct viral proliferation of neuropathogenic and nonneuropathogenic murine leukemia viruses in rat glial cells. J Virol (1999) 0.81
Evolution of different antiviral strategies in wild mouse populations exposed to different gammaretroviruses. Curr Opin Virol (2013) 0.81
Naturally Occurring Polymorphisms of the Mouse Gammaretrovirus Receptors CAT-1 and XPR1 Alter Virus Tropism and Pathogenicity. Adv Virol (2011) 0.80
Removal of either N-glycan site from the envelope receptor binding domain of Moloney and Friend but not AKV mouse ecotropic gammaretroviruses alters receptor usage. Virology (2009) 0.79
Postentry restriction of Mason-Pfizer monkey virus in mouse cells. J Virol (2014) 0.78
Native structure of a retroviral envelope protein and its conformational change upon interaction with the target cell. J Struct Biol (2016) 0.75
Endogenous retrovirus particles and their repercussion effects on the growth behaviour of continuous hybridoma cultivation processes. Cytotechnology (2001) 0.75
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A (1988) 9.35
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science (1989) 8.73
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell (1989) 7.64
A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res (1988) 7.28
Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature (1991) 5.40
Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature (1991) 4.84
The CD4 antigen: physiological ligand and HIV receptor. Cell (1988) 4.42
The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature (1988) 3.47
Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell (1988) 3.40
Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature (1988) 2.53
Progress toward human gene therapy. Science (1989) 2.26
Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci U S A (1988) 2.21
The MHC-binding and gp120-binding functions of CD4 are separable. Science (1989) 1.77
CD4: collaborator in immune recognition and HIV infection. Cell (1990) 1.59
Molecular cloning and characterization of a novel human gene homologous to the murine ecotropic retroviral receptor. Virology (1991) 1.58
Efficient site directed in vitro mutagenesis using ampicillin selection. Nucleic Acids Res (1990) 1.30
Gene therapy. Sci Am (1990) 1.09
Molecular cloning and characterization of a novel human gene homologous to the murine ecotropic retroviral receptor. Virology (1991) 1.58
Genetic control of radiation leukemia virus-induced tumorigenesis. I. Role of the major murine histocompatibility complex, H-2. J Exp Med (1977) 1.54
Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia. J Exp Med (1978) 1.53
Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol (1997) 1.39
Efficient in vivo microRNA targeting of liver metastasis. Oncogene (2010) 1.36
A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes. J Exp Med (1979) 1.20
Hypericin as an inactivator of infectious viruses in blood components. Transfusion (1995) 1.19
Association of endogenous viral loci with genes encoding murine histocompatibility and lymphocyte differentiation antigens. Proc Natl Acad Sci U S A (1983) 1.15
Viral sequences are associated with many histocompatibility genes. Immunogenetics (1986) 1.15
In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia. Proc Natl Acad Sci U S A (1980) 1.13
Effect of type I and type II interferons on murine thymocyte surface antigen expression: induction or selection? Cell Immunol (1981) 1.11
Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J (1993) 1.07
Genetic control of radiation leukemia virus-induced tumorigenesis II. Influence of Srlv-1, a locus not linked to H-2. J Exp Med (1977) 1.04
Association of mouse liver adenosine 3':5'-cyclic monophosphate (cyclic AMP) levels with histocompatibility-2 genotype. Proc Natl Acad Sci U S A (1975) 1.04
Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Acad Sci U S A (1989) 1.04
Genetic control of cell-mediated responsiveness to an AKR tumor-associated antigen: mapping of the locus involved to the I region of the H-2 complex. J Exp Med (1977) 1.01
A TCR gamma delta cell recognizing a novel TL-encoded gene product. Cold Spring Harb Symp Quant Biol (1989) 1.01
Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor. Cancer Gene Ther (2009) 1.00
Evidence for a major cluster of lymphocyte differentiation antigens on murine chromosome 2. Proc Natl Acad Sci U S A (1982) 1.00
Pituitary-thyroid activity and longevity in neonatally thyroxine-treated rats. Mech Ageing Dev (1983) 0.96
Lack of class I H-2 antigens in cells transformed by radiation leukemia virus is associated with methylation and rearrangement of H-2 DNA. Proc Natl Acad Sci U S A (1986) 0.96
Extraribosomal functions associated with the C terminus of the 37/67 kDa laminin receptor are required for maintaining cell viability. Cell Death Dis (2010) 0.95
Inactivation of the human immunodeficiency virus by hypericin: evidence for photochemical alterations of p24 and a block in uncoating. AIDS Res Hum Retroviruses (1992) 0.95
Long-range physical map of the Ly-6 complex: mapping the Ly-6 multigene family by field-inversion and two-dimensional gel electrophoresis. Genomics (1992) 0.95
Genetics of susceptibility for radiation-induced leukemia. Mapping of genes involved to chromosomes 1, 2, and 4, and implications for a viral etiology in the disease. J Exp Med (1981) 0.95
The biological function of the major histocompatibility complex: hypotheses. Contemp Top Immunobiol (1980) 0.92
A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Br J Cancer (1999) 0.92
Isolation of a retroviruslike sequence from the TL locus of the C57BL/10 murine major histocompatibility complex. J Virol (1986) 0.90
Induction of leukemia by both fractionated x-irradiation and radiation leukemia virus involves loci in the chromosome 2 segment H-30-A. Proc Natl Acad Sci U S A (1983) 0.90
The chemical and biological properties of hypericin--a compound with a broad spectrum of biological activities. Med Res Rev (1995) 0.90
Arthroscopic management of tibial plateau fractures--comparison with open reduction method. Arch Orthop Trauma Surg (2003) 0.90
Functional properties of Ly 11.2 lymphocytes: a role for these cells in leukemia? J Immunol (1980) 0.90
Recent studies on the role of the immune response in resistance to virus-induced leukemias and lymphomas. Semin Hematol (1978) 0.89
A novel cDNA transcript expressed in fractionated X-irradiation-induced murine thymomas. Cell Growth Differ (1996) 0.89
Enhanced gene expression of the murine ecotropic retroviral receptor and its human homolog in proliferating cells. J Virol (1992) 0.89
Murine leukemia virus sequences are encoded in the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1984) 0.88
Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin. Photochem Photobiol (2000) 0.88
'Bystander killing' induces apoptosis and is inhibited by forskolin. Gene Ther (1995) 0.87
Assignment of the Ly-6--Ril-1--Sis--H-30--Pol-5/Xmmv-72--Ins-3--Krt-1--Int-1 --Gdc-1 region to mouse chromosome 15. Immunogenetics (1987) 0.87
Definition of a new T lymphocyte cell surface antigen, Ly 11.2. J Immunol (1980) 0.87
Cell-specific targeting of a thymidine kinase/ganciclovir gene therapy system using a recombinant Sindbis virus vector. Int J Cancer (1999) 0.87
Retrovirus vectors displaying the IgG-binding domain of protein A. Biochem Mol Med (1997) 0.86
Identification of a 36,000-molecular weight, gag-related phosphoprotein in lymphoma cells transformed by radiation leukemia virus. J Exp Med (1984) 0.85
H-2D control of leukaemia susceptibility: mechanism and implications. J Immunogenet (1980) 0.85
H-2D control of radiation leukemia virus induced neoplasia: evidence for interaction of viral and H-2 genomic information. Transplant Proc (1981) 0.83
Cell-specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector. Biochem Biophys Res Commun (1998) 0.83
A method for the quantitation of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography. Anal Biochem (1991) 0.82
A novel method of cell-specific mRNA transfection. Mol Genet Metab (1998) 0.82
Expression of a single major histocompatibility complex locus controls the immune response to poly-L-(tyrosine, glutamic acid)-poly-DL-alanine-poly-L-lysine. J Exp Med (1978) 0.81
Genetics of resistance to virus-induced leukemias. Adv Cancer Res (1983) 0.81
Controlled propagation of replication-competent Sindbis viral vector using suicide gene strategy. Gene Ther (2008) 0.80
Extension of the H-2 TLb molecular map. Isolation and characterization of T13, T14, and T15 from the C57BL/6 mouse. Immunogenetics (1988) 0.80
Ly 11.2: a cell surface antigen that may identify murine lymphocytes susceptible to transformation by oncogenic agents. Fed Proc (1981) 0.79
The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan. Cancer Gene Ther (2012) 0.79
Genomic organization of the mouse Tla locus: study of an endogenous retroviruslike locus reveals polymorphisms related to different Tla haplotypes. Immunogenetics (1988) 0.79
Murine thymomas induced by fractionated-X-irradiation have specific T-cell receptor rearrangements and characteristics associated with day-15 to -16 fetal thymocytes. Mol Cell Biol (1987) 0.79
Cell-specific, multidrug delivery system using streptavidin-protein A fusion protein. Biochem Mol Med (1996) 0.78
Study on the rapid deswelling mechanism of comb-type N-isopropylacrylamide gels. Colloids Surf B Biointerfaces (2004) 0.78
[Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer]. Gan To Kagaku Ryoho (1998) 0.78
Targeted gene transfer system using a streptavidin-transforming growth factor-alpha chimeric protein. DNA Cell Biol (1999) 0.78
Restricted tissue tropism and acquired resistance to Sindbis viral vector expression in the absence of innate and adaptive immunity. Gene Ther (2007) 0.78
Reducing cytotoxicity induced by Sindbis viral vectors. Mol Genet Metab (1999) 0.77
[Administration of clarithromycin (CAM) to non-small cell lung cancer]. Jpn J Antibiot (2000) 0.77
Activation transcription factor 1 involvement in the regulation of murine H-2Dd expression. J Biol Chem (1997) 0.77
Photodynamic inactivation of radiation leukemia virus produced from hypericin-treated cells. Virology (1993) 0.77
A molecular and genetic approach to understanding the mechanisms by which fractionated X-irradiation induces leukemia in mice. Leuk Res (1986) 0.77
Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for treatment of T cell-mediated diseases. Int Immunol (2000) 0.76
Sindbis viral vectors target hematopoietic malignant cells. Cancer Gene Ther (2012) 0.76
Effects of fractionated x-irradiation on the Ly-6--Ril-1--Pol-5 region. Immunogenetics (1990) 0.76
Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase. Gynecol Oncol (1999) 0.76
Infection of human cells by murine ecotropic viruses: retroviral vectors carrying the hygromycin resistance-encoding gene. Gene (1996) 0.75
Phosphoproteins recognized by an H-2-linked immune response gene and their association with cell proliferation. Cancer Res (1987) 0.75
[Clinical evaluation of anaerobic infections in patients with bronchopulmonary infections diagnosed by transtracheal aspiration]. Kansenshogaku Zasshi (1999) 0.75
Precise mapping of the gene for Ly-21.2 on the 7th chromosome. J Immunogenet (1982) 0.75
Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex. DNA Cell Biol (2000) 0.75
Conservation of the H-2 BF1 binding motif 5' of the H-2Ds, Ks and Dq genes. Eur J Immunogenet (1997) 0.75
Transduction of a murine dominant negative activation transcription factor 1 increases cell surface expression of the class I MHC on a human epidermoid tumor cell line. Int Immunol (2000) 0.75
[A survey on inpatients' misgivings and timing of intervention; using an anxiety scale test]. Kango Gijutsu (1984) 0.75
Regulation of H-2 class I gene expression in virally transformed and infected cells. Crit Rev Immunol (1988) 0.75
A new murine lymphocyte alloantigen, Ly-21.2, mapping to the seventh chromosome. Immunogenetics (1982) 0.75
The regulation of murine H-2Dd expression by activation transcription factor 1 and cAMP response element binding protein. J Immunol (1998) 0.75
Heterogeneity of p15(E)-related polypeptides expressed by MuLV-infected cells. Virology (1985) 0.75
Isolation of virus-like (VL30) elements from the Q10 and D regions of the major histocompatibility complex. Biochem Genet (1991) 0.75
Reverse genetics approaches for cloning RIL-1, a major locus involved in susceptibility to leukemia. Curr Top Microbiol Immunol (1988) 0.75
[Clinical evaluation of lung abscess diagnosed by transtracheal aspiration]. Kansenshogaku Zasshi (1998) 0.75
Relationship between leukemia virus genomes and histocompatibility genes. Year Immunol (1985) 0.75
[Bacillus cereus septicemia in a patient with severe aplastic anemia]. Kansenshogaku Zasshi (1998) 0.75
[Systemic management of patients under anti-infection treatment]. Nihon Naika Gakkai Zasshi (1998) 0.75
[A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. Nihon Kokyuki Gakkai Zasshi (1999) 0.75
Genomic analysis and localization of murine Deltex, a modulator of notch activity, to mouse chromosome 5 and its human homolog to chromosome 12. DNA Cell Biol (2001) 0.75
[A clinical study of respiratory infection isolating non-pathogenic Neisseria by transtracheal aspiration]. Kansenshogaku Zasshi (1998) 0.75
Multi-drug delivery system using streptavidin-transforming growth factor-alpha chimeric protein. DNA Cell Biol (1996) 0.75
[Usefulness of power Doppler sonography for the assessment of subpleural lesions]. Nihon Kokyuki Gakkai Zasshi (1999) 0.75
Cell targeting for gene delivery: use of fusion protein containing the modified human receptor for ecotropic murine leukemia virus. Biochem Mol Med (1995) 0.75
An assay for adenyl cyclase based on a combination of sodium borate electrophoresis and paper chromatography. Anal Biochem (1975) 0.75
A new lymphocyte cell surface antigen, Ly-22.2, controlled by a locus on chromosome 4 and a second unlinked locus. J Immunol (1983) 0.75